Answers are grounded in this paper and cite their sources.
Women with a known diagnosis of PCOS who exhibited oligo/anovulation and hyperandrogenism demonstrated an increase of metabolic disorders. These results suggest that metabolic screening, before conception or in the early stages of pregnancy, can be beneficial particularly in women with PCOS phenotypes A and B. Early screening and identification may justify enhanced maternal fetal surveillance to improve maternal and fetal morbidity among women affected with PCOS.
No takes yet. Share an insight, caveat, or question.
Ashrafi et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: